Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HØJBJERGKLINIKKEN, KIROPRAKTOR ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.8% 1.7% 1.6% 2.1% 2.3% 4.4% 19.2% 19.2%   Credit score (0-100)   73 74 74 66 64 46 7 7   Credit rating   A A A A BBB BBB B B   Credit limit (kDKK)   2.1 5.2 11.9 0.6 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,380 7,248 5,811 5,970 6,050 6,386 0.0 0.0   EBITDA   629 708 566 449 114 163 0.0 0.0   EBIT   507 598 538 420 64.4 36.7 0.0 0.0   Pre-tax profit (PTP)   605.5 731.5 695.6 580.5 240.4 91.1 0.0 0.0   Net earnings   468.6 568.1 542.3 454.0 186.6 70.6 0.0 0.0   Pre-tax profit without non-rec. items   605 732 696 580 240 91.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   206 153 125 162 113 405 0.0 0.0   Shareholders equity total   3,799 4,367 4,909 5,363 5,550 196 15.7 15.7   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 540 0.0 0.0   Balance sheet total (assets)   4,491 5,101 6,132 6,156 6,109 1,308 15.7 15.7   Net Debt   -733 -236 -1,414 -476 -425 272 -15.7 -15.7     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,380 7,248 5,811 5,970 6,050 6,386 0.0 0.0   Gross profit growth   0.5% 13.6% -19.8% 2.7% 1.3% 5.6% -100.0% 0.0%   Employees   8 9 9 9 9 9 0 0   Employee growth %   14.3% 12.5% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,491 5,101 6,132 6,156 6,109 1,308 16 16   Balance sheet change%   9.9% 13.6% 20.2% 0.4% -0.8% -78.6% -98.8% 0.0%   Added value   506.8 597.7 538.5 420.1 64.4 36.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -244 -220 -56 8 -99 166 -405 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.9% 8.2% 9.3% 7.0% 1.1% 0.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.4% 15.4% 12.6% 9.6% 4.0% 2.5% 0.0% 0.0%   ROI %   17.3% 18.1% 15.2% 11.4% 4.5% 2.9% 0.0% 0.0%   ROE %   13.1% 13.9% 11.7% 8.8% 3.4% 2.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   84.6% 85.6% 80.1% 87.1% 90.8% 15.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -116.6% -33.3% -249.7% -106.1% -373.5% 166.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 275.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   6.0 6.6 4.8 7.4 10.6 0.8 0.0 0.0   Current Ratio   6.1 6.7 4.9 7.6 10.7 0.8 0.0 0.0   Cash and cash equivalent   733.3 235.6 1,414.3 476.2 425.5 268.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,535.4 4,213.5 4,783.6 5,200.9 5,437.0 -209.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   63 66 60 47 7 4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   79 79 63 50 13 18 0 0   EBIT / employee   63 66 60 47 7 4 0 0   Net earnings / employee   59 63 60 50 21 8 0 0